Capricor: Q4 Earnings Snapshot
By AP News
Published - Mar 15, 2023, 06:56 PM ET
Last Updated - Jun 22, 2023, 03:58 PM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Capricor Therapeutics Inc. (CAPR) on Wednesday reported a loss of $7.7 million in its fourth quarter.
The San Diego-based company said it had a loss of 31 cents per share.
The biotechnology company posted revenue of $959,900 in the period. Its adjusted revenue was $960,000.
For the year, the company reported that its loss widened to $29 million, or $1.18 per share. Revenue was reported as $2.6 million.
